Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia

Tarun Singhal, Steven Cicero, Seth A. Gale, Nicolas Horan, Shipra Dubey, Gad A. Marshall, Howard L. Weiner

Open source

DOI
10.1097/rlu.0000000000005955
Published
2025-05-13
Container
Clinical Nuclear Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/rlu.0000000000005955,
  title = {Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia},
  author = {Tarun Singhal and Steven Cicero and Seth A. Gale and Nicolas Horan and Shipra Dubey and Gad A. Marshall and Howard L. Weiner},
  year = {2025},
  journal = {Clinical Nuclear Medicine},
  doi = {10.1097/rlu.0000000000005955},
  url = {https://doi.org/10.1097/rlu.0000000000005955}
}

RIS

TY  - JOUR
TI  - Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia
AU  - Tarun Singhal
AU  - Steven Cicero
AU  - Seth A. Gale
AU  - Nicolas Horan
AU  - Shipra Dubey
AU  - Gad A. Marshall
AU  - Howard L. Weiner
PY  - 2025
JO  - Clinical Nuclear Medicine
DO  - 10.1097/rlu.0000000000005955
UR  - https://doi.org/10.1097/rlu.0000000000005955
ER  - 

APA

Singhal, T., Cicero, S., Gale, S. A., Horan, N., Dubey, S., Marshall, G. A., & Weiner, H. L. (2025). Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer’s Disease Dementia. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000005955

Source records